Phase 3 Clinical Study
Links shared publicly online about this topic
Phase 3 clinical study results of bazedoxifene released
news-medical.net — “Wyeth Pharmaceuticals, a division of Wyeth, announces findings from a placebo-controlled Phase 3 study of bazedoxifene 20 mg extended to five years, which indicated a significant reduction versus placebo in new vertebral fractures in postmenopausal women with osteoporosis.” View full resource at news-medical.net
Most Recently Shared on September 15, 2009 at 7:13 pm By:
News-Medical.Net Health News and Oncology
Oncology News: Phase 3 clinical study results of bazedoxifene released: Wyeth Pharmaceuticals, a d.. http://bit.ly/M3NrP
Anthera Enrolls First Patients In Pivotal Varespladib Phase 3 Clinical Study
medicalnewstoday.com — “Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, announced patient enroll” View full resource at medicalnewstoday.com
Most Recently Shared on June 24, 2010 at 12:33 pm By:
MNT Pharma News Health News and Pharma
Anthera Enrolls First Patients In Pivotal Varespladib Phase 3 Clinical Study http://mnt.to/3Fjg #pharma #pharmaceutical
Opexa Completes Successful Meetings With FDA To Pursue Phase 3 Clinical Study For Tovaxin(R) In Multiple Sclerosis
medicalnewstoday.com — “Opexa Therapeutics, Inc. (NASDAQ:OPXA), a leading cell therapy company developing Tovaxin® for multiple sclerosis (MS), announced the successful completion of two separate meetings with the U.” View full resource at medicalnewstoday.com
Most Recently Shared on January 10, 2011 at 11:41 am By:
Opexa Completes Successful Meetings With FDA To Pursue Phase 3 Clinical Study For Tovaxin(R) In Multiple Scleros... http://mnt.to/f/3PMs
Phase 3 Clinical Study Of A New Cancer Immunotherapy Extends Survival In Patients With Refractory Melanoma
medicalnewstoday.com — “The Cancer Research Institute, a nonprofit organization dedicated to the development of immune system-based treatments for cancer, announced its celebration of a significant new breakthrough in th” View full resource at medicalnewstoday.com
Most Recently Shared on June 8, 2010 at 1:07 pm By:
Phase 3 Clinical Study Of A New Cancer Immunotherapy Extends Survival In Patients With Refractory Melanoma http://mnt.to/3DC9 #healthnews
Gilead’s Quad Phase 3 clinical study in treatment-naïve HIV-1 patients meets 48-week primary objective
news-medical.net — “Gilead Sciences, Inc. today announced that the second pivotal Phase 3 clinical trial of its investigational fixed-dose, single-tablet "Quad" regimen of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate, being evaluated for HIV-1 infection in treatment-naïve patients, met its primary objective of non-inferiority at week 48 as compared to ritonavir-boosted atazanavir plus Truvada.” View full resource at news-medical.net
Most Recently Shared on September 20, 2011 at 12:46 pm By:
Gilead’s Quad Phase 3 clinical study in treatment-naïve HIV-1 patients meets 48-week primary objective: Gilead S... http://t.co/EPIoX6sg
Tolerx Presents Research At European Diabetes Meeting And Enrolls First Patient In Europe In The DEFEND-2 Phase 3 Clinical Study In Type 1 Diabetes
medicalnewstoday.com — “Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, announced the presentation of preclinical research descr” View full resource at medicalnewstoday.com
Most Recently Shared on September 24, 2010 at 8:05 pm By:
Tolerx Presents Research At European Diabetes Meeting And Enrolls First Patient In Europe In The DEFEND-2 Phase 3 Clin... http://mnt.to/3Khq
The Lancet Publishes Data From Protege, MacroGenics' Phase 3 Clinical Study Of Teplizumab In Type 1 Diabetes Patients
medicalnewstoday.com — “MacroGenics, Inc., a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, announced the publication in The Lancet of” View full resource at medicalnewstoday.com
Most Recently Shared on June 29, 2011 at 7:05 am By:
The Lancet Publishes Data From Protege, MacroGenics' Phase 3 Clinical Study Of Teplizumab In Type 1 Diabetes Patients http://mnt.to/3XLN
Gilead's Investigational Antiretroviral Quad Regimen Meets 48-Week Primary Objective in Pivotal Phase 3 Clinical Study 102 - Drugs.com MedNews
drugs.com — “Aug 15, 2011 - Gilead Sciences, Inc. (Nasdaq GILD) today announced that a Phase 3 clinical trial (Study 102) of its investigational fixed-dose, single-tablet Qu” View full resource at drugs.com
Most Recently Shared on August 15, 2011 at 4:03 pm By:
Drugs and Devices OW OW Health
Gilead's Investigational Antiretroviral Quad Regimen Meets 48-Week Primary Objective in Pivotal Phase 3 Cl... http://t.co/6So1tUN #drug
The Lancet Publishes Data from Protege, MacroGenics' Phase 3 Clinical Study of Teplizumab in Type 1 Diabetes Patients - Drugs.com MedNews
drugs.com — “MacroGenics, Inc., a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, announ” View full resource at drugs.com
Most Recently Shared on June 30, 2011 at 2:12 pm By:
Drugs and Devices OW OW Health
The Lancet Publishes Data from Protege, MacroGenics' Phase 3 Clinical Study of Teplizumab in Type 1 Diabet... http://bit.ly/ljrdS5 #drug
Phase 3 clinical study demonstrates efficiency of metformin therapy in type 2 diabetes | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com
keyvive.com — “Phase 3 clinical study demonstrates efficiency of metformin therapy in type 2 diabetes | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com” View full resource at keyvive.com
Most Recently Shared on September 25, 2010 at 7:39 am By:
Phase 3 clinical study demonstrates efficiency of metformin therapy in type 2 diabetes… http://goo.gl/fb/1HOBu
Tolerx Presents Research At European Diabetes Meeting And Enrolls First Patient In Europe In The DEFEND-2 Phase 3 Clinical Study In Type 1 Diabetes | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com
keyvive.com — “Tolerx Presents Research At European Diabetes Meeting And Enrolls First Patient In Europe In The DEFEND-2 Phase 3 Clinical Study In Type 1 Diabetes | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com” View full resource at keyvive.com
Most Recently Shared on September 27, 2010 at 7:13 pm By:
Tolerx Presents Research At European Diabetes Meeting And Enrolls First Patient In Europe In… http://goo.gl/fb/0l1uQ
Tibotec Starts Global Phase 3 Clinical Trials Studying TMC435 In Adults With Chronic Genotype 1 HCV
medicalnewstoday.com — “Tibotec Pharmaceuticals announced that two global, registrational phase 3 trials are recruiting patients to examine TMC435, its investigational hepatitis C protease inhibitor, in treatment-nave” View full resource at medicalnewstoday.com
Most Recently Shared on February 21, 2011 at 1:05 pm By:
Tibotec Starts Global Phase 3 Clinical Trials Studying TMC435 In Adults With Chronic Genotype 1 HCV http://mnt.to/3Rnp #liver #hepatitis
BMS, AstraZeneca say phase 3 study of diabetes drug dapagliflozin meets endpoint - Clinical Trials
pharmabiz.com — “Bristol-Myers Squibb Company (BMS) and AstraZeneca announced results from a randomized, double blind phase 3 clinical study, which demonstrated that the addition of the investigational drug dapagliflozin” View full resource at pharmabiz.com
Most Recently Shared on September 22, 2010 at 7:46 am By:
Urology & Nephrology OW Health
BMS, AstraZeneca say phase 3 study of diabetes drug dapagliflozin meets endpoint: Bristol-Myers Squibb Company (BM... http://bit.ly/b1BhoO
Neoprobe Initiates Third Phase 3 Lymphoseek Study
medicalnewstoday.com — “Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, announced that a third multi-center Phase 3 clinical study of Lymphoseek® (” View full resource at medicalnewstoday.com
Most Recently Shared on July 9, 2010 at 1:05 pm By:
MNT Clinical Trials Health News
Neoprobe Initiates Third Phase 3 Lymphoseek Study http://mnt.to/3FSM #clinicaltrials
Clinical Trial: A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialysis - Renal and Urology News
renalandurologynews.com — “A look at the following clinical trial: A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialysis” View full resource at renalandurologynews.com
Most Recently Shared on March 12, 2010 at 3:46 pm By:
Renal Urology News Urology, Medical Publisher, Health News, and Nephrology
Clinical Trial: A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialy... http://bit.ly/chiZt8
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
News-Medical.Net
Stay up to date with the latest Oncology news and research via News-Medical.Net
-
MNT Pharma News
The latest pharma industry news published daily. Articles from research centers, universities and prestigious journals.
-
OrganizedWisdom MS
Organizing multiple sclerosis resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
